IP Library › Granted Patent US 11,311,726
Granted Patent B2
US 11,311,726 · App. 16/275,892 · Granted Apr 26, 2022

Neuromodulation system and method for transitioning between programming modes

Inventors: Dennis Allen Vansickle (Lancaster, CA); Dongchul Lee (Agua Dulce, CA); Sridhar Kothandaraman (Valencia, CA); Que T. Doan (West Hills, CA); Changfang Zhu (Valencia, CA); Jordi Parramon (Valencia, CA); Justin Holley (Vejle, DK); Bradley L. Hershey (Carrollton, TX); Christopher E. Gillespie (Stevenson Ranch, CA); Rafael Carbunaru (Valley Village, CA); Nazim Wahab (Valencia, CA)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/36071A61N1/36185A61N1/37247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,311,726
App. No.
16/275,892
Granted
Apr 26, 2022
Kind
B2
Abstract

An external control device, neuromodulation system, and method of providing therapy to a patient using an implantable neuromodulator implanted within the patient. Electrical modulation energy is delivered from the neuromodulator to the patient in accordance with the pre-existing modulation program when in one of the super-threshold delivery mode and the sub-threshold delivery mode. Operation of the neuromodulator is switched to the other of the super-threshold delivery mode and the sub-threshold delivery mode. A new modulation program may be derived from a pre-existing modulation program, and the neuromodulator may deliver the electrical modulation energy to the patient in accordance with the pre-existing modulation program during the other of the super-threshold delivery mode and the sub-threshold delivery mode.

Claims (30)

1. A neuromodulation system comprising: an external control device for programming an implantable neuromodulator coupled to an electrode array implanted within a patient, wherein the external control device comprises:

a user interface configured for receiving at least one user input;

telemetry circuitry configured for communicating with the neuromodulator; and

controller/processor circuitry configured for responding to the at least one user input by instructing the neuromodulator to deliver super-threshold modulation, including determining a super-threshold modulation parameter set for the super-threshold modulation that is effective in treating pain, determining a sub-threshold modulation parameter set for sub-threshold modulation based on the super-threshold modulation parameter set, and instructing the neuromodulator to deliver the sub-threshold modulation to treat the pain, wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set have different pulse rates,

wherein the determining the sub-threshold modulation parameter set includes computing a pulse amplitude value for the sub-threshold modulation parameter set as a percentage within a range of 30% to 70% of the pulse amplitude value of the super-threshold modulation parameter set.

2. The neuromodulation system of claim 1 , wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set have different pulse widths.

3. The neuromodulation system of claim 1 , wherein the super-threshold modulation parameter set has a pulse width value greater than 200 μs.

4. The neuromodulation system of claim 1 , wherein the super-threshold modulation parameter set defines an active recharge for the super-threshold modulation.

5. The neuromodulation system of claim 1 , wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set provide different electrode fractionalizations.

6. The system of claim 1 , wherein the implantable neuromodulator includes a spinal cord stimulator (SCS) to deliver spinal cord stimulation.

7. A method of providing therapy to a patient using a neuromodulation system that includes an external control device and an implantable neuromodulator, comprising responding to at least one user input through a user interface of the external control device to perform a process, including:

instructing the neuromodulator to deliver modulation energy to the patient including determining a super-threshold modulation parameter set for the super-threshold modulation that is effective in treating pain;

determining a sub-threshold modulation parameter set for sub-threshold modulation based on the super-threshold modulation parameter set; and

instructing the neuromodulator to deliver the sub-threshold modulation to treat the pain, wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set have different pulse rates,

wherein the determining the sub-threshold modulation parameter set includes computing a pulse amplitude value for the sub-threshold modulation parameter set as a percentage within a range of 30% to 70% of the pulse amplitude value of the super-threshold modulation parameter set.

8. The method of claim 7 , wherein the super-threshold modulation parameter set defines an active recharge.

9. The method of claim 7 , wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set provide different electrode fractionalizations.

10. The method of claim 7 , wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set have different pulse widths.

11. The method of claim 7 , wherein the super-threshold modulation parameter set has a pulse width value greater than 200 μs.

12. The method of claim 7 , wherein the implantable neuromodulator includes a spinal cord stimulator (SCS) to deliver spinal cord stimulation.

13. A non-transitory machine-readable medium including instructions, which when executed by a machine, cause the machine to perform a process, comprising responding to at least one user input through a user interface to perform a process, including:

instructing a neuromodulator to deliver modulation energy to the patient including determining a super-threshold modulation parameter set for the super-threshold modulation that is effective in treating pain;

determining a sub-threshold modulation parameter set for sub-threshold modulation based on the super-threshold modulation parameter set, wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set have different pulse rates; and

instructing the neuromodulator to deliver the sub-threshold modulation to treat the pain,

wherein the determining the sub-threshold modulation parameter set includes computing a pulse amplitude value for the sub-threshold modulation parameter set as a percentage within a range of 30% to 70% of the pulse amplitude value of the super-threshold modulation parameter set.

14. The non-transitory machine-readable medium of claim 13 , wherein the super-threshold modulation parameter set defines an active recharge.

15. The non-transitory machine-readable medium of claim 13 , wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set provide different electrode fractionalizations.

16. The non-transitory machine-readable medium of claim 13 , wherein the super-threshold modulation parameter set and the sub-threshold modulation parameter set have different pulse widths.

17. The non-transitory machine-readable medium of claim 13 , wherein the super-threshold modulation parameter set has a pulse width value greater than 200 μs.

18. The non-transitory machine-readable medium of claim 13 , wherein the implantable neuromodulator includes a spinal cord stimulator (SCS) to deliver spinal cord stimulation.

Continuity (3)
Continuation 14214752 · Mar 15, 2014
Provisional Application 61801917 · Mar 15, 2013
Related Publication 20190184168A1 · Jun 20, 2019
Cited By (2)
US 12,201,837 US 12,533,516